Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,000
Closed -$1.48M 5621
2021
Q3
$1.48M Hold
10,000
﹤0.01% 3283
2021
Q2
$1.51M Buy
+10,000
New +$1.39M ﹤0.01% 3204

Other funds holding OMCL

David Shaw's OMCL Position: Q2 2026 in Review

David Shaw reduced its Omnicell (OMCL) stake by 46% in Q2 2026, selling an estimated $9.96M and leaving 287,461 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #1682.

David Shaw first reported a position in OMCL in Q4 2014 and has held it in 38 quarters since. The position peaked at $48.8M in Q1 2025. 304 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • David Shaw held 287,461 shares of Omnicell worth $11.9M as of Q2 2026.
  • David Shaw sold 247,150 Omnicell shares in Q2 2026, an estimated $9.96M.
  • Omnicell made up 0.01% of David Shaw's portfolio in Q2 2026, its #1682 holding.
  • David Shaw first reported a position in Omnicell in Q4 2014 and has held it in 38 quarters since.
  • David Shaw's Omnicell position peaked at $48.8M in Q1 2025.
  • 304 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.